Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

Overview of attention for article published in Science Translational Medicine, April 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 102 news outlets
blogs: 1 blog
twitter: 33 X users
patent: 3 patents

facebook: 1 Facebook page
reddit: 1 Redditor
f1000: 1 research highlight platform

Readers on

mendeley: 158 Mendeley

So far, Altmetric has seen 34 X posts from 33 X users, with an upper bound of 352,513 followers.

RT @BryanDChoi: Congratulations @EvginLab, @RVilePhD and colleagues @MayoClinic! Check out their work @ScienceTM describing how CAR T cells…

Congratulations @EvginLab, @RVilePhD and colleagues @MayoClinic! Check out their work @ScienceTM describing how CAR T cells and oncolytic viruses can be used in combination to treat brain tumors! https://t.co/N0A78NICVa https://t.co/QOrOueDg65

Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice https://t.co/sD5vrjjdi1

Congratulations to GSC Scientist, Dr. Laura Evgin, on her publication in @ScienceTM on Chimeric antigen receptor (CAR) T cell #CancerImmunotherapy #CancerResearch

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 30 additional X posts.